224 related articles for article (PubMed ID: 10347229)
41. Identification of a domain within the carboxyl-terminal region of the beta platelet-derived growth factor (PDGF) receptor that mediates the high transforming activity of PDGF.
Uren A; Yu JC; Li W; Chung IY; Mahadevan D; Pierce JH; Heidaran MA
J Biol Chem; 1996 May; 271(19):11051-4. PubMed ID: 8626645
[TBL] [Abstract][Full Text] [Related]
42. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells.
Sharfe N; Freywald A; Toro A; Roifman CM
J Immunol; 2003 Jun; 170(12):6024-32. PubMed ID: 12794130
[TBL] [Abstract][Full Text] [Related]
43. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases.
Szymkiewicz I; Kowanetz K; Soubeyran P; Dinarina A; Lipkowitz S; Dikic I
J Biol Chem; 2002 Oct; 277(42):39666-72. PubMed ID: 12177062
[TBL] [Abstract][Full Text] [Related]
44. Oncogenic forms of Cbl abrogate the anchorage requirement but not the growth factor requirement for proliferation.
Ojaniemi M; Langdon WY; Vuori K
Oncogene; 1998 Jun; 16(24):3159-67. PubMed ID: 9671395
[TBL] [Abstract][Full Text] [Related]
45. A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes.
Ribon V; Printen JA; Hoffman NG; Kay BK; Saltiel AR
Mol Cell Biol; 1998 Feb; 18(2):872-9. PubMed ID: 9447983
[TBL] [Abstract][Full Text] [Related]
46. The Src-like adaptor protein regulates PDGF-induced actin dorsal ruffles in a c-Cbl-dependent manner.
Sirvent A; Leroy C; Boureux A; Simon V; Roche S
Oncogene; 2008 May; 27(24):3494-500. PubMed ID: 18193084
[TBL] [Abstract][Full Text] [Related]
47. The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation.
Lin H; Martelli MP; Bierer BE
Int Immunol; 2001 Jan; 13(1):13-22. PubMed ID: 11133830
[TBL] [Abstract][Full Text] [Related]
48. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
[TBL] [Abstract][Full Text] [Related]
49. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
Bisson SA; Ujack EE; Robbins SM
Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836
[TBL] [Abstract][Full Text] [Related]
50. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.
Blake RA; Broome MA; Liu X; Wu J; Gishizky M; Sun L; Courtneidge SA
Mol Cell Biol; 2000 Dec; 20(23):9018-27. PubMed ID: 11074000
[TBL] [Abstract][Full Text] [Related]
51. Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination.
Guo X; Nie L; Esmailzadeh L; Zhang J; Bender JR; Sadeghi MM
J Biol Chem; 2009 Oct; 284(43):29376-82. PubMed ID: 19696027
[TBL] [Abstract][Full Text] [Related]
52. The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation.
Toffalini F; Kallin A; Vandenberghe P; Pierre P; Michaux L; Cools J; Demoulin JB
Haematologica; 2009 Aug; 94(8):1085-93. PubMed ID: 19644140
[TBL] [Abstract][Full Text] [Related]
53. Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts.
Feshchenko EA; Shore SK; Tsygankov AY
Oncogene; 1999 Jun; 18(25):3703-15. PubMed ID: 10391678
[TBL] [Abstract][Full Text] [Related]
54. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
55. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
[TBL] [Abstract][Full Text] [Related]
56. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells.
Ota Y; Beitz LO; Scharenberg AM; Donovan JA; Kinet JP; Samelson LE
J Exp Med; 1996 Nov; 184(5):1713-23. PubMed ID: 8920860
[TBL] [Abstract][Full Text] [Related]
57. Negative regulation of Lck by Cbl ubiquitin ligase.
Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
[TBL] [Abstract][Full Text] [Related]
58. The c-Cbl oncoprotein.
Lupher ML; Andoniou CE; Bonita D; Miyake S; Band H
Int J Biochem Cell Biol; 1998 Apr; 30(4):439-44. PubMed ID: 9675877
[TBL] [Abstract][Full Text] [Related]
59. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
60. Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration.
Wardega P; Heldin CH; Lennartsson J
Cell Signal; 2010 Sep; 22(9):1363-8. PubMed ID: 20494825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
